The Evolving Diabetes Burden in the United States

  1. Michael M. Engelgau, MD, MS;
  2. Linda S. Geiss, MS;
  3. Jinan B. Saaddine, MD, MPH;
  4. James P. Boyle, PhD;
  5. Stephanie M. Benjamin, PhD;
  6. Edward W. Gregg, PhD;
  7. Edward F. Tierney, MPH;
  8. Nilka Rios-Burrows, MPH;
  9. Ali H. Mokdad, PhD;
  10. Earl S. Ford, MD;
  11. Giuseppina Imperatore, MD, PhD; and
  12. K. M. Venkat Narayan, MD, MPH
  1. From the National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

    Abstract

    A diabetes epidemic emerged during the 20th century and continues unchecked into the 21st century. It has already taken an extraordinary toll on the U.S. population through its acute and chronic complications, disability, and premature death. Trend data suggest that the burden will continue to increase. Efforts to pre- vent or delay the complications of diabetes or, better yet, to prevent or delay the development of diabetes itself are urgently needed.

    Article and Author Information

    • Potential Financial Conflicts of Interest: None disclosed.

    • Requests for Single Reprints: Michael M. Engelgau, MD, MS, Centers for Disease Control and Prevention, Mailstop K-10, 4770 Buford Highway NE, Atlanta, GA 30341; e-mail, mxe1{at}cdc.gov.

    • Current Author Addresses: Drs. Engelgau, Saaddine, Boyle, Benjamin, Gregg, Mokdad, Ford, Imperatore, and Narayan; Ms. Geiss and Rios-Burrows; and Mr. Tierney: Centers for Disease Control and Prevention, Mailstop K-10, 4770 Buford Highway NE, Atlanta, GA 30341.

    Comments on This Article

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement